VARIANTES DE QUEUE DE THERAPEUTIQUES REDOX-ACTIVES DESTINEES AU TRAITEMENT DE MALADIES MITOCHONDRIALES ET D'AUTRES ETATS ET A LA MODULATION DE BIOMARQUEURS ENERGETIQUES

摘要

Methods of treating or suppressing mitochondrial diseases, such as Friedreich's ataxia (FRDA), Leber's Hereditary Optic Neuropathy (LHON), mitochondrial myopathy, encephalopathy, lactacidosis, stroke (MELAS), or Kearns-Sayre Syndrome (KSS) are disclosed, as well as compounds useful in the methods of the invention. Energy biomarkers useful in assessing the metabolic state of a subject and the efficacy of treatment are also disclosed.